White blood cell subtypes as predictors of adverse cardiac events

Gisela A Kristono1,2, Ana S Holley1,2, Scott A Harding2,3

  • 1Department of Surgery and Anaesthesia, University of Otago Wellington.

Insights

White blood cell ratios like neutrophil-lymphocyte ratio (NLR) and lymphocyte-monocyte ratio (LMR) showed initial promise for predicting major adverse cardiovascular events (MACE) in acute myocardial infarction (AMI) patients. However, these ratios were not independently predictive in multivariate analysis.

Area of Science:

  • Cardiology
  • Hematology
  • Biomarkers

Background:

  • White blood cell (WBC) subtypes are linked to major adverse cardiovascular events (MACE) in acute myocardial infarction (AMI).
  • Neutrophil-lymphocyte ratio (NLR) and lymphocyte-monocyte ratio (LMR) have emerged as potential predictors of MACE.
  • Investigating the prognostic value of specific WBC subtypes and their ratios in AMI is crucial.

Purpose of the Study:

  • To confirm the association between MACE and WBC subtypes (neutrophils, lymphocytes, monocytes).
  • To evaluate the predictive capability of neutrophil-lymphocyte ratio (NLR) and lymphocyte-monocyte ratio (LMR) for MACE in AMI patients.
  • To determine if NLR and LMR retain prognostic significance in a multivariate model.

Main Methods:

  • A cohort of 860 acute myocardial infarction (AMI) patients was analyzed.
  • White blood cell (WBC) subtype levels were collected from initial blood tests before angiography.
  • One-year outcomes, including major adverse cardiovascular events (MACE), and baseline demographics were recorded.

Main Results:

  • 15.1% of patients experienced MACE within one year.
  • Univariate analysis revealed significant associations between MACE and both NLR (P=0.006) and LMR (P=0.005).
  • In multivariate analysis, neither NLR nor LMR showed significant association with MACE after adjusting for clinical factors (P > 0.05).

Conclusions:

  • NLR and LMR were not independently predictive of MACE in AMI patients when considered alongside other clinical variables.
  • The prognostic value of NLR and LMR alone is limited for clinical application in AMI.
  • Further research is needed to explore the utility of these ratios in conjunction with other inflammatory markers for MACE prediction.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
468
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
704
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
152
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
246
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
418
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
792